Skip to main content
Evidence-led patent and technology research

Patent Granted In India To Indofil Chemicals Company A Division Of Indofil Organic Industries Ltd

The archived GIPResearch article associates Indian patent 373917 with an Indofil Chemical Company synergistic fungicidal composition involving mancozeb and hexaconazole. The old article cites an August 2021 patent journal and gives ingredient ranges, but the present review has not obtained the official grant claims or current rights extract. This case study explains how a combination-formulation patent should be analyzed without treating an old promotional summary as a current legal opinion.

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
GIPResearch illustration supporting Patent Granted In India To Indofil Chemicals Company A Division Of Indofil Organic Industries Ltd
Research focusEvidence before conclusions

Identify source documents and material limitations relevant to the subject.

Decision contextClarify the technical question

Compare the available information with the specific invention or platform facts.

Research outputTraceable next steps

Document what is supported, uncertain or requires specialist analysis.

Substantive research and evidence

Patent Granted In India To Indofil Chemicals Company A Division Of Indofil Organic Industries Ltd — research analysis

Verification alert: P0: historical report of IN 373917 is not a verified current status, ownership or claims opinion.

Patent number and applicant

The first file check must establish patent number, application, filing date, priority, grant publication and correct applicant name. The phrase 'a division of Indofil Organic Industries Ltd' in historical text may reflect a particular corporate arrangement; subsequent reorganizations or assignments require direct documentation. Distinguish the bibliographic applicant from current proprietor and permitted licensees. The exact file should be matched with its claims, not just a patent journal headline, because different application stages can contain materially different compositions. Evidence checkpoint: Retrieve the official Indofil IN 373917 grant and verify the company's correct applicant and later assignment history. The record should include its issuing body, date, context and exact language. Where sources diverge, identify the conflict before converting this observation into a technical or legal conclusion.

Division/successor ownership

The original article describes mancozeb as a dithiocarbamate fungicide and hexaconazole as a triazole component. A combination claim may specify concentrations, wetting agents, suspending agents, stabilizers and optional fillers, along with a particular formulation form. These are leads, not a substitute for the granted independent claim. Identify whether the asserted ranges are from the final claim, an embodiment or merely a description. A composition within the same broad class may still omit a necessary numerical range or additive requirement. Evidence checkpoint: Check whether quoted mancozeb, hexaconazole and auxiliary ranges appear in granted independent claims. Compare the result with a plausible alternative explanation, since similarity of terms is not proof of equivalence. A reviewer should be able to repeat the comparison using the same underlying material.

Formulation or chemical invention

Synergy is a technical claim that should be supported by comparative evidence, not accepted because two active ingredients were combined. Check experimental methods, control treatments, statistical treatment, disease target, application rate and crop conditions. The article claims improved efficacy and yield, but these outcomes may depend on test design and cannot be generalized without data. Compare the observed joint effect with a credible additive baseline. Patentability and agricultural registration are separate questions even if a mixture performs favorably in an experiment. Evidence checkpoint: Require comparative efficacy controls before describing a mixture as synergistic or a crop-yield result as general. Retain the actual technical document or contractual clause supporting the finding. The decision-maker needs to know whether this is a binding limitation, a design option, or an unsupported assertion.

Visual framework for Patent Granted In India To Indofil Chemicals Company A Division Of Indofil Organic Industries Ltd
Analytical illustration — use source documents for the underlying facts.

Independent and dependent claims

The historical narrative reports a section 3(d) objection and applicant response emphasizing that the claimed combination was new. Novelty alone does not establish every patentability requirement, and the actual objection may concern particular claim language or known components. Recover the office action, supporting prior art and amendments before summarizing the Controller's final reasoning. Distinguish what the applicant asserted from what the Controller decided. An argument made during prosecution is not equivalent to a binding conclusion about all possible competing formulations. Evidence checkpoint: Inspect the exact section 3(d) objections, evidence and issued amendments rather than repeating the applicant's advocacy. Record both supporting and adverse materials. An unexplained gap or contradiction is a reason to narrow the claim, not to add confident wording to an informational webpage.

Prosecution and current register

A recent legal-status check should confirm renewal, recorded assignments, grants, lapses, court or opposition actions and the current claim text. Even a currently effective Indian patent operates territorially; international family filings may have different limits. Manufacture or sale of fungicidal compositions also raises product safety and licensing requirements outside this patent analysis. Do not describe an allegedly successful patented product as free of third-party rights or assume all compositions containing both active ingredients infringe. Evidence checkpoint: Confirm renewals, proceedings and territory and keep agricultural product permissions separate from patent rights. Use a source date and relevant geography when the legal or operational position can change. An old document may be valuable history but should not be presented as a current certification.

Technology comparisons

Prior-art searching should focus on earlier mancozeb–triazole combinations, formulation excipients, ranges, preparation methods and claimed synergy experiments. A comparator must account for relevant timing and whether earlier publications disclosed each essential technical element. A patent's use of familiar actives does not by itself prove obviousness, just as an asserted yield benefit does not establish inventive step. Review formulation claims and test data together, with clear separation between laboratory observations and legal conclusions. Evidence checkpoint: Compare earlier mancozeb–triazole formulation references using identical ingredient and effect criteria. Connect the outcome to a concrete next action: search a claim, change a document, test a control or ask for specialist review. A general statement of importance is not enough.

Original analytical framework and decision implications

An original composition matrix would map each allegedly claimed constituent to its numerical range, function, example and closest earlier formulation. A second artifact would test the synergy claim by documenting controls, endpoints and whether the published evidence supports a non-additive effect. Both require the verified official patent and experimental record. Preserve the old 2021 article in the editorial archive, but publish precise current-status statements only after a fresh patent-register check.

How to commission a reproducible evidence review

A useful research commission on fungicidal composition has a narrow scope: What does the Indofil patent record show about ownership, claims and relevance to commercial formulations?. The analyst should first establish the evidence relevant to patent number and applicant and division/successor ownership, then test formulation or chemical invention and independent and dependent claims against competing evidence. Only after those records are compared should the report address prosecution and current register and technology comparisons. The inquiry should record source identities, dates, assumptions, and contradictory documents. This order matters: a positive finding from one database, a promotional description, or an attractive technical diagram cannot resolve an unknown legal condition. Where the evidence is incomplete, the proper output is an explicit next search or test rather than a confident result.

Evidence register and research deliverables

A practical deliverable for fungicidal composition is a dated source-to-claim or source-to-control register, with one row for each of the six questions above. The first field records the proposition being tested; the second links to the primary evidence, and the third states what alternative explanation has been considered. For this page, the proposed distinctive output is: Ownership chain and claim-element matrix after verification. A research packet should also record which evidence is missing and who is authorized to make the consequential decision. The source hierarchy should start with IP India granted specification, then use technical publications and comparable records to interpret—not replace—the primary evidence. The resulting report should make the boundary between historical narrative, observed technical facts, legal interpretation and untested commercial hypotheses plain to readers.

Sources and verification boundaries

The following are authoritative sources or official discovery portals for the relevant methodology. A patent-office search portal is not itself evidence that any named patent currently remains in force. Claims about an individual case require its underlying file.

  • https://ipindia.gov.in/pages/e-services
  • https://patentscope.wipo.int/

Related research

Author and disclaimer

Research editorial draft for GIPResearch.com. The site is an information and research platform. This article is not personalized legal advice, a current patent-register certificate, a freedom-to-operate opinion, or a guarantee of any regulatory or commercial result. Verify material claims with current primary records. Full disclaimer.

Research checklist: what to verify before you decide

Use this checklist to assess the evidence behind patent granted in india to indofil chemicals company a division of indofil organic industries ltd rather than relying on a single summary or marketing claim.

  1. Patent number and applicant
  2. Division/successor ownership
  3. Formulation or chemical invention
  4. Independent and dependent claims
  5. Prosecution and current register
  6. Technology comparisons
  7. Original analytical framework and decision implications
  8. How to commission a reproducible evidence review

Official sources and research starting points

These are research starting points. Specific factual and legal conclusions require checking the underlying documents and dates.

  1. https://ipindia.gov.in/pages/e-services
  2. https://patentscope.wipo.int/

Featured Work & Insights